Your fact-checks will appear here
Ivermectin has shown preclinical promise in treating various types of cancer
Preclinical work identifies strongest anticancer signals for ivermectin in breast cancer, hematologic malignancies (notably leukemia), hepatocellular carcinoma, and several drug-resistant solid tumor ...
Clinical testing of ivermectin in cancer patients remains nascent: searches of the clinical literature and trial registries identify essentially one active early-phase trial combining ivermectin with ...
Oncologists cite a cluster of regulatory and ethical concerns about repurposing antiparasitics like ivermectin for cancer: there is a stark gap between promising lab data and human evidence, known tox...